Human ZC3H13/KIAA0853/Xio ORF/cDNA clone-Adenovirus particle (NM_015070.6)

Cat. No.: vGMAD001289

Pre-made Human ZC3H13/KIAA0853/Xio Adenovirus for ZC3H13 overexpression in-vitro and in-vivo. The ZC3H13 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified ZC3H13-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAD001289 Human ZC3H13 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAD001289
Gene Name ZC3H13
Accession Number NM_015070.6
Gene ID 23091
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 4695 bp
Gene Alias KIAA0853,Xio
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGTCAAAAATTAGAAGGAAGGTCACAGTGGAAAATACCAAGACTATATCTGATAGCACATCCCGAAGACCCAGTGTATTTGAGAGGCTTGGACCCAGCACTGGCAGTACAGCAGAGACACAGTGCCGTAACTGGCTGAAGACTGGCAACTGCCTCTATGGAAACACATGTAGATTCGTACATGGCCCTTCACCTCGTGGTAAAGGTTATAGCAGCAATTATAGAAGGTCACCAGAAAGACCTACAGGGGATCTTAGAGAAAGAATGAAGAACAAGCGCCAAGACGTGGACACTGAGCCCCAGAAACGAAATACAGAGGAGTCATCCTCACCTGTTAGGAAAGAATCTTCAAGAGGGAGACATAGGGAAAAGGAAGACATAAAAATCACTAAGGAAAGAACTCCAGAAAGTGAAGAAGAAAATGTAGAATGGGAAACTAATAGAGATGATTCTGACAATGGAGATATTAATTATGATTATGTTCATGAATTGTCATTGGAAATGAAGCGTCAGAAGATACAGAGGGAATTAATGAAGCTGGAACAAGAAAACATGGAGAAGAGAGAAGAAATTATCATTAAAAAGGAGGTTTCACCAGAAGTGGTTAGATCAAAATTGTCCCCGTCACCTTCTCTAAGAAAGTCTAGCAAATCTCCGAAGCGAAAATCAAGCCCGAAGTCGTCTTCAGCTAGCAAGAAAGATAGGAAGACATCTGCAGTATCTTCTCCCCTGTTGGACCAGCAGAGAAATTCAAAAACCAACCAAAGTAAAAAGAAAGGACCACGTACTCCTAGTCCACCCCCTCCTATACCAGAAGATATCGCTCTGGGGAAAAAATACAAAGAAAAATATAAAGTAAAAGACAGGATAGAAGAAAAAACAAGAGATGGAAAGGACAGAGGACGAGATTTTGAACGACAAAGAGAAAAGAGAGACAAGCCAAGGTCTACTTCCCCAGCAGGACAGCATCATTCTCCTATATCTTCTAGACATCACTCATCTTCCTCACAATCAGGATCATCTATTCAAAGACATTCTCCTTCTCCTCGTCGAAAAAGAACTCCTTCACCATCTTATCAGCGGACACTAACTCCACCTTTACGACGCTCTGCCTCTCCTTATCCTTCACATTCTTTGTCGTCTCCCCAGAGAAAGCAGAGTCCTCCAAGACATCGCTCTCCAATGCGAGAGAAAGGGAGACATGATCATGAACGAACTTCACAGTCTCATGATCGACGCCATGAAAGGAGGGAAGATACTAGGGGCAAACGAGACAGAGAAAAGGACTCAAGAGAAGAACGAGAATATGAACAGGATCAGAGCTCTTCTAGAGACCACAGAGATGACAGAGAACCTCGAGATGGTCGGGATCGGAGAGATGCCAGAGATACTAGGGACCGAAGGGAACTAAGAGACTCCAGAGACATGCGGGACTCAAGGGAGATGAGAGATTATAGCAGAGATACCAAAGAGAGCCGTGATCCCAGAGATTCTCGGTCCACTCGTGATGCCCATGACTACAGGGACCGTGAAGGTCGAGATACTCATCGAAAGGAGGATACATATCCAGAAGAATCCCGGAGTTATGGCCGAAACCATTTGAGAGAAGAAAGTTCTCGTACGGAAATAAGGAATGAGTCCAGAAATGAGTCTCGAAGTGAAATTAGAAATGACCGAATGGGCCGAAGTAGGGGGAGGGTTCCTGAGTTACCTGAAAAGGGAAGTCGAGGCTCAAGAGGTTCTCAAATTGATAGTCACAGTAGTAATAGCAACTATCATGACAGCTGGGAAACTCGAAGTAGCTATCCTGAAAGAGATAGATATCCTGAAAGAGACAACAGAGATCAAGCAAGGGATTCTTCCTTTGAGAGAAGACATGGAGAGCGAGACCGTCGTGACAACAGAGAGAGAGATCAAAGACCAAGCTCACCAATTCGACATCAGGGAAGGAATGACGAGCTTGAGCGTGATGAAAGAAGAGAGGAACGAAGAGTAGACAGAGTGGATGATAGGAGAGATGAAAGGGCTAGAGAGAGAGATCGGGAACGAGAACGAGACAGGGAGCGGGAGAGAGAGAGGGAACGTGAACGGGATCGGGAAAGAGAAAAAGAGAGAGAACTAGAAAGAGAGCGTGCTAGGGAACGGGAGAGAGAAAGAGAAAAAGAGAGAGATCGTGAAAGGGATAGAGACCGAGACCACGATCGAGAGCGGGAAAGAGAGAGGGAACGAGACAGGGAAAAAGAACGGGAACGAGAAAGAGAAGAGAGAGAGAGGGAGAGAGAGCGAGAACGGGAGAGAGAGCGAGAGCGAGAACGGGAACGAGAAAGAGCGAGAGAAAGGGATAAAGAACGAGAACGCCAAAGGGATTGGGAAGACAAAGACAAAGGACGAGATGACCGCAGAGAAAAGCGAGAAGAGATCCGAGAAGATAGGAATCCAAGAGATGGACATGATGAAAGAAAATCAAAGAAGCGCTATAGAAATGAAGGGAGTCCCAGCCCTAGACAGTCCCCGAAGCGCCGGCGTGAACATTCTCCGGACAGTGATGCCTACAACAGTGGAGATGATAAAAATGAAAAACACAGACTCTTGAGCCAAGTTGTACGACCTCAAGAATCTCGTTCTCTTAGTCCCTCGCACCTCACAGAAGACAGACAGGGTAGATGGAAAGAGGAGGATCGTAAACCAGAAAGGAAAGAGAGTTCAAGGCGCTACGAAGAACAGGAACTCAAGGAGAAAGTTTCTTCTGTAGATAAACAGAGAGAACAGACAGAAATCCTGGAAAGCTCAAGAATGCGTGCACAGGACATTATAGGACACCACCAGTCTGAAGATCGAGAGACATCTGATCGAGCTCATGATGAAAACAAGAAGAAAGCAAAAATTCAAAAGAAACCAATTAAGAAAAAGAAAGAGGATGATGTTGGAATAGAGAGGGGTAACATAGAGACAACATCTGAAGATGGTCAAGTATTTTCACCAAAAAAAGGACAGAAAAAGAAAAGCATTGAAAAAAAACGTAAAAAATCCAAAGGTGATTCTGATATTTCTGATGAAGAAGCAGCCCAGCAAAGTAAGAAGAAAAGAGGCCCACGGACTCCCCCTATAACAACTAAAGAGGAATTGGTTGAAATGTGCAATGGTAAGAATGGTATTCTAGAGGACTCCCAGAAAAAAGAAGATACAGCATTCAGTGACTGGTCTGATGAGGATGTCCCTGACCGTACAGAGGTGACAGAAGCAGAGCATACTGCCACCGCCACGACTCCTGGTAGTACCCCTTCTCCTCTATCTTCTCTTCTTCCTCCTCCACCGCCTGTGGCTACTGCCACTGCTACAACTGTGCCTGCAACTCTTGCTGCCACTACTGCTGCTGCCGCCACCTCTTTCAGCACATCTGCCATCACTATTTCCACCTCTGCCACCCCCACCAATACCACCAATAATACTTTTGCCAATGAAGACTCACACAGAAAATGCCACAGAACACGAGTAGAAAAAGTAGAGACGCCTCACGTGACTATAGAAGATGCACAGCATCGCAAGCCTATGGATCAAAAGAGGAGCAGCAGCCTCGGGAGCAATCGGAGTAACCGTAGTCATACGTCTGGTCGTCTTCGCTCCCCATCCAATGATTCAGCCCATCGAAGTGGAGATGACCAAAGTGGTCGAAAGAGAGTACTGCACAGTGGCTCAAGAGATAGAGAAAAAACAAAAAGCCTGGAAATCACAGGAGAGAGAAAATCTAGGATTGATCAGTTAAAGCGTGGAGAACCCAGTCGAAGTACTTCTTCAGATCGCCAGGATTCAAGAAGCCATAGTTCAAGAAGAAGTTCTCCAGAGTCAGATCGACAGGTCCATTCAAGATCTGGGTCATTTGATAGCAGAGACAGGCTTCAAGAACGAGATCGATATGAACACGACAGAGAGCGCGAGAGAGAGAGGAGAGATACGAGGCAGAGAGAATGGGACCGAGATGCTGATAAAGATTGGCCACGCAACAGGGATCGAGATAGATTGCGAGAACGAGAACGAGAGAGAGAACGAGACAAAAGGAGAGACTTGGATAGGGAAAGAGAGAGACTAATTTCTGATTCTGTTGAAAGGGACAGGGACAGAGACAGAGACAGAACTTTTGAGAGTTCTCAAATAGAGTCTGTGAAACGCTGTGAAGCAAAACTGGAAGGTGAACATGAAAGGGATCTAGAAAGCACTTCCCGAGACTCTCTAGCCTTGGATAAAGAGAGAATGGATAAAGATCTGGGATCTGTGCAGGGATTTGAAGAAACAAATAAATCCGAGAGAACTGAGAGTCTGGAAGCAGGAGATGACGAGTCCAAGTTAGATGATGCACATTCATTAGGCTCTGGTGCTGGAGAAGGATACGAGCCAATCAGTGATGACGAACTAGATGAAATTCTGGCAGGTGATGCAGAAAAGAGGGAGGACCAACAGGATGAGGAGAAGATGCCAGATCCCTTAGATGTGATAGATGTGGATTGGTCTGGTCTTATGCCAAAGCATCCAAAAGAACCACGAGAGCCTGGGGCTGCACTCTTAAAATTCACACCTGGAGCTGTTATGCTAAGAGTTGGGATTTCTAAAAAGTTGGCAGGTTCTGAACTCTTTGCCAAAGTCAAAGAAACATGTCAGAGACTTTTAGAAAAACCCAAAGGTAGTTTCATTTTACTTTAA
ORF Protein Sequence MSKIRRKVTVENTKTISDSTSRRPSVFERLGPSTGSTAETQCRNWLKTGNCLYGNTCRFVHGPSPRGKGYSSNYRRSPERPTGDLRERMKNKRQDVDTEPQKRNTEESSSPVRKESSRGRHREKEDIKITKERTPESEEENVEWETNRDDSDNGDINYDYVHELSLEMKRQKIQRELMKLEQENMEKREEIIIKKEVSPEVVRSKLSPSPSLRKSSKSPKRKSSPKSSSASKKDRKTSAVSSPLLDQQRNSKTNQSKKKGPRTPSPPPPIPEDIALGKKYKEKYKVKDRIEEKTRDGKDRGRDFERQREKRDKPRSTSPAGQHHSPISSRHHSSSSQSGSSIQRHSPSPRRKRTPSPSYQRTLTPPLRRSASPYPSHSLSSPQRKQSPPRHRSPMREKGRHDHERTSQSHDRRHERREDTRGKRDREKDSREEREYEQDQSSSRDHRDDREPRDGRDRRDARDTRDRRELRDSRDMRDSREMRDYSRDTKESRDPRDSRSTRDAHDYRDREGRDTHRKEDTYPEESRSYGRNHLREESSRTEIRNESRNESRSEIRNDRMGRSRGRVPELPEKGSRGSRGSQIDSHSSNSNYHDSWETRSSYPERDRYPERDNRDQARDSSFERRHGERDRRDNRERDQRPSSPIRHQGRNDELERDERREERRVDRVDDRRDERARERDRERERDRERERERERERDREREKERELERERAREREREREKERDRERDRDRDHDRERERERERDREKEREREREERERERERERERERERERERERARERDKERERQRDWEDKDKGRDDRREKREEIREDRNPRDGHDERKSKKRYRNEGSPSPRQSPKRRREHSPDSDAYNSGDDKNEKHRLLSQVVRPQESRSLSPSHLTEDRQGRWKEEDRKPERKESSRRYEEQELKEKVSSVDKQREQTEILESSRMRAQDIIGHHQSEDRETSDRAHDENKKKAKIQKKPIKKKKEDDVGIERGNIETTSEDGQVFSPKKGQKKKSIEKKRKKSKGDSDISDEEAAQQSKKKRGPRTPPITTKEELVEMCNGKNGILEDSQKKEDTAFSDWSDEDVPDRTEVTEAEHTATATTPGSTPSPLSSLLPPPPPVATATATTVPATLAATTAAAATSFSTSAITISTSATPTNTTNNTFANEDSHRKCHRTRVEKVETPHVTIEDAQHRKPMDQKRSSSLGSNRSNRSHTSGRLRSPSNDSAHRSGDDQSGRKRVLHSGSRDREKTKSLEITGERKSRIDQLKRGEPSRSTSSDRQDSRSHSSRRSSPESDRQVHSRSGSFDSRDRLQERDRYEHDRERERERRDTRQREWDRDADKDWPRNRDRDRLRERERERERDKRRDLDRERERLISDSVERDRDRDRDRTFESSQIESVKRCEAKLEGEHERDLESTSRDSLALDKERMDKDLGSVQGFEETNKSERTESLEAGDDESKLDDAHSLGSGAGEGYEPISDDELDEILAGDAEKREDQQDEEKMPDPLDVIDVDWSGLMPKHPKEPREPGAALLKFTPGAVMLRVGISKKLAGSELFAKVKETCQRLLEKPKGSFILL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMAD001289 Human ZC3H13 Adenovirus plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.